Lorenz Muller - Mar 21, 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Commercial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MIST
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 09:46 PM
Next filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Employee Stock Option Grant (right to buy) Award $0 +160K $0.00 160K Mar 21, 2022 Common Shares 160K $5.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option vest on March 23, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.